Jacqueline Jufen Zhu (Jacqueline J Zhu)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Transcription Factor

Diffuse Large B Cell Lymphoma

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Man Wu, Pok Man Hau, Linxian Li, Chi Man Tsang, Yike Yang, Aziz Taghbalout, Grace Tin-Yun Chung, Shin Yee Hui, Wing Chung Tang, Nathaniel Jillette, Jacqueline Jufen Zhu, Horace Hok Yeung Lee, Ee Ling Kong, Melissa Sue Ann Chan, Jason Ying-Kuen Chan, Brigette Buig Yue Ma, Mei-Ru Chen, Charles Lee, Ka-Fai To, Albert Wu Cheng, Kwok-Wai Lo
Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers. Nature communications 15 (1) (2024)
Man Wu, Pok Man Hau, Linxian Li, Chi Man Tsang, Yike Yang, Aziz Taghbalout, Grace Tin-Yun Chung, Shin Yee Hui, Wing Chung Tang, Nathaniel Jillette, Jacqueline Jufen Zhu, Horace Hok Yeung Lee, Ee Ling Kong, Melissa Sue Ann Chan, Jason Ying-Kuen Chan, Brigette Buig Yue Ma, Mei-Ru Chen, Charles Lee, Ka-Fai To, Albert Wu Cheng, Kwok-Wai Lo
Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers. Nature communications 15 (1) (2024)
Man Wu, Pok Man Hau, Linxian Li, Chi Man Tsang, Yike Yang, Aziz Taghbalout, Grace Tin-Yun Chung, Shin Yee Hui, Wing Chung Tang, Nathaniel Jillette, Jacqueline Jufen Zhu, Horace Hok Yeung Lee, Ee Ling Kong, Melissa Sue Ann Chan, Jason Ying-Kuen Chan, Brigette Buig Yue Ma, Mei-Ru Chen, Charles Lee, Ka-Fai To, Albert Wu Cheng, Kwok-Wai Lo
Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers. Nature communications 15 (1) (2024)
Man Wu, Pok Man Hau, Linxian Li, Chi Man Tsang, Yike Yang, Aziz Taghbalout, Grace Tin-Yun Chung, Shin Yee Hui, Wing Chung Tang, Nathaniel Jillette, Jacqueline Jufen Zhu, Horace Hok Yeung Lee, Ee Ling Kong, Melissa Sue Ann Chan, Jason Ying-Kuen Chan, Brigette Buig Yue Ma, Mei-Ru Chen, Charles Lee, Ka-Fai To, Albert Wu Cheng, Kwok-Wai Lo
Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers. Nature communications 15 (1) (2024)
Patricia A Clow, Menghan Du, Nathaniel Jillette, Aziz Taghbalout, Jacqueline Jufen Zhu, Albert Wu Cheng
CRISPR-mediated multiplexed live cell imaging of nonrepetitive genomic loci with one guide RNA per locus. Nature communications 13 (1) (2022)
Ruhul Amin, Anjali Shukla, Jacqueline Jufen Zhu, Sohyoung Kim, Ping Wang, Simon Zhongyuan Tian, Andy D Tran, Debasish Paul, Steven D Cappell, Sandra Sczerba Burkett, Huaitian Liu, Maxwell Ping Lee, Michael J Kruhlak, Jennifer E Dwyer, R Mark Simpson, Gordon L Hager, Yijun Ruan, Kent W Hunter
Nuclear pore protein NUP210 depletion suppresses metastasis through heterochromatin-mediated disruption of tumor cell mechanical response. Nature communications 12 (1) (2021)
Mourad Wagdy Ali, C Pawan K Patro, Jacqueline Jufen Zhu, Christopher H Dampier, Sarah J Plummer, Cem Kuscu, Mazhar Adli, Ching C Lau, Rose K Lai, Graham Casey
A functional variant on 20q13.33 related to glioma risk alters enhancer activity and modulates expression of multiple genes. Human mutation 42 (1) (2020)